Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate and Metformin for Weight Loss in Obesity
NCT00349635Phase 2Completed
- Sponsor
- Solvay
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Fenofibrate + Metformin, Metformin and Placebo (3 arms). Primary endpoint: Body Weight at 6 months. Started Oct 2004; status: completed.
02
Drugs
fenofibratemetformin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00349635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349635.